Why Accutane Works (And What It Costs

The dermatologist had her hand on the prescription pad. My son was sixteen. We'd been working on his skin for almost a year — antimicrobials, gut protocols, the carnivore diet, glutathione, supplements I couldn't pronounce. We had moved the needle. We had not finished the job.

She said the word: Accutane. And I was sitting there remembering being his exact age, in a chair just like this one, with my own dermatologist saying the same word. I took it. I cleared. Twenty years later I would learn what it had cost me.

This article is the conversation I would have had with myself at sixteen if I'd known then what I know now. It is not anti-Accutane. The drug works. It is, however, an honest accounting of what it does and what it costs — so that anyone making this decision can make it with the full information instead of half.

What Accutane actually does

Accutane is the brand name (now discontinued in the U.S. but the term lingers) for isotretinoin, a synthetic derivative of vitamin A. It's now sold under generic names: Absorica, Claravis, Myorisan, Zenatane, and others. All are the same molecule.

Mechanistically, isotretinoin does several things, but the dominant action is this: it shuts down sebaceous glands. It binds to retinoic acid receptors inside the sebaceous gland and triggers what is essentially controlled cellular suicide of the sebum-producing cells. The glands shrink to a fraction of their previous size. Sebum output drops by 80 to 90 percent.

No sebum, no follicle clogging. No follicle clogging, no bacterial proliferation. No proliferation, no inflammation. No inflammation, no acne. The cascade we covered in the previous articles in this series doesn't get a chance to start, because the sebum at the top of it is no longer there.

This is why Accutane works when nothing else does. It doesn't address why the sebum was overproducing. It just removes the sebum. And for a meaningful percentage of users — depending on the study, somewhere between 40 and 85 percent — the effect is permanent. The glands never fully recover. Acne is "cured" because the organ that produces it has been functionally disabled.

"It doesn't address why the sebum was overproducing. It just removes the sebum."

The side effects everyone knows about

The Accutane side effect profile is well documented. Some of it makes it into the consent forms; some of it requires you to read the package insert carefully. The standard list:

• Severe dryness — skin, lips, eyes, nasal passages. This is universal. Some patients develop chronic dry eye that persists after the course ends.
• Joint and muscle pain — common, particularly in the lower back and hips. Most patients experience some level of it.
• Initial breakout / "purge" — the first 1-2 months of treatment often worsen acne before clearing.
• Photosensitivity — increased sunburn risk and pigmentation changes.
• Mood changes — the FDA carries a black-box warning for depression and suicidal ideation. The peer-reviewed evidence on this is mixed; some meta-analyses find a signal, others don't. What is consistent across studies is that some subset of patients experiences significant mood effects.
• Severe teratogenicity — Accutane causes severe birth defects. This is why female patients in the U.S. are enrolled in the iPLEDGE program and required to use two forms of birth control.

These are the documented short-term side effects. They are real, well-studied, and disclosed before treatment starts. They are not what this article is about.

What the consent form doesn't always cover

What I want to cover here is what the side effect literature is less consistent about: the long-term metabolic load on the liver that Accutane creates and that, in a subset of patients, persists for years or decades after treatment ends.

Isotretinoin is metabolized in the liver, primarily through the cytochrome P450 enzyme system (Phase I detoxification). The metabolites are then conjugated through Phase II — the same Phase II conjugation pathway we covered in the previous article — and excreted. For a healthy liver with adequate substrate, this is manageable. For a liver that was already running short on substrate — which describes most modern adults to some degree — it can deplete the system substantially.

This is not speculation. Routine liver enzyme monitoring (ALT, AST) is part of standard Accutane care precisely because the drug raises liver enzymes in a meaningful percentage of patients. Most clinicians manage this by watching the numbers and adjusting the dose. What is less commonly discussed is what happens after the course ends and the visible signs return to normal — but the substrate pools may not.

I took Accutane in my early twenties. My liver enzymes returned to "normal" range within months of stopping. I felt fine. I had clear skin. The story, by all conventional measures, had ended well.

What followed, over the next twenty years, was a constellation of issues I never connected to the drug at the time:

• Chronic low-grade liver inflammation that no doctor could explain
• Multiple autoimmune-spectrum issues that emerged in my thirties
• Increasing sensitivity to alcohol, medications, and environmental toxins
• The slow accumulation of fatigue, brain fog, and the sense that something was always running just below the surface

I cannot prove the Accutane caused these. I can tell you that I have spent the last decade working to repair what looks, on lab work, exactly like a Phase II conjugation pathway that's been running on insufficient substrate for years. I can also tell you that the literature on long-term post-Accutane effects is sparse, because most follow-up studies end at one or two years. The five-, ten-, twenty-year picture has not been rigorously studied.

The decision frame

None of this is to say nobody should ever take Accutane. The drug is appropriate for some patients — typically those with severe, scarring, nodulocystic acne that has been thoroughly worked up and has not responded to less aggressive interventions. For some patients, the trade-offs are worth it.

What I want to flag is the frame in which most Accutane decisions actually get made. The typical path is:

1. Patient has persistent acne
2. Topical treatments are tried for a few months
3. Oral antibiotics are tried for a few more months
4. Results are partial, patient is frustrated, dermatologist suggests Accutane
5. Risks are reviewed in a 10-15 minute conversation
6. Prescription is written

What is almost never part of that path: a workup of why the acne is happening in the first place. Has hormone clearance been assessed? Has Phase II conjugation capacity been considered? Has dietary sulfur intake been evaluated? Has the gut microbiome been looked at?

If none of those upstream factors have been addressed, the question to ask isn't "is Accutane worth the risk?" The question is: "have I actually tried the interventions that target what's causing this in the first place — or have I only been trying interventions that target the downstream symptoms?"

The first question can't be answered honestly until the second one has been worked through. And in my experience, when the upstream interventions are run with discipline, the answer to "is Accutane necessary?" is often no.

What we did instead

When my son's dermatologist suggested Accutane, I knew I was sitting at a fork. We could take the drug — and likely clear his skin in three to six months. Or we could try to do what I had been trying to do for myself for the past decade: restore the upstream pathway that should have been doing this work all along.

I told her I wanted to try one more thing first. She was professional about it. She also told me, with confidence, that she did not believe what I was going to try would work.

The thing I tried was the protocol I have written about in the previous articles in this series and laid out in full in Clear From Within. Three steps. Specific compounds, specific doses, specific timing. The whole architecture aimed at restoring Phase II conjugation, bile flow, and the cofactor minerals the system needs.

His acne — along with the eczema he had also been dealing with — was visibly clearing within five days. By two weeks it was effectively gone. He has not had a meaningful breakout since.

I cannot promise you the same result. I can tell you that I'm not alone — there are many people for whom this protocol has worked when nothing else did. And I can tell you that the cost of trying it before the Accutane prescription is roughly $60 in supplements and a few weeks of patience. The cost of trying it after Accutane is much harder to estimate. I know, because I'm still paying that one twenty years later.

If you're staring at a prescription pad

The argument I would make to anyone — or any parent of anyone — facing the Accutane decision is this:

Take a beat. Read the protocol. Spend six to eight weeks running it with discipline before you fill the Accutane prescription. If it works, you have saved yourself an unknown amount of long-term liver load. If it doesn't, the Accutane prescription is still there, your dermatologist is still there, and you've lost only six weeks and the cost of a $17 ebook and a few supplements.

That is not an anti-pharmaceutical argument. It's a sequencing argument. Try the upstream intervention before the systemic one. The drug works — but it works by disabling an organ. Disabling an organ should not be the first move when restoring its function is also on the table.

This article is educational, not medical advice. Accutane is a serious medication that has helped many patients. The framework in this article is one perspective from someone who took the drug, has dealt with what he believes are long-term effects of that course, and made a different choice for his son. Anyone considering changes to a prescribed regimen should consult their prescribing physician.